Related references
Note: Only part of the references are listed.Clinical Relevance and Therapeutic Significance of MicroRNA-133a Expression Profiles and Functions in Malignant Osteosarcoma-Initiating Cells
Tomohiro Fujiwara et al.
STEM CELLS (2014)
Quantification of peripheral blood CD133 mRNA in identifying metastasis and in predicting recurrence of patients with clear cell renal cell carcinoma
Gang Feng et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
CD133 positive cells isolated from A549 cell line exhibited high liver metastatic potential
H. Zhang et al.
NEOPLASMA (2014)
CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome
Ana Gvozdenovic et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
CD 133+ and CXCR4+ colon cancer cells as a marker for lymph node metastasis
Jennifer Silinsky et al.
JOURNAL OF SURGICAL RESEARCH (2013)
The Prognostic Significance of CD44V6, CDH11, and β-Catenin Expression in Patients with Osteosarcoma
Zhouming Deng et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells
Min Yang et al.
CANCER SCIENCE (2011)
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo
Virginia Tirino et al.
FASEB JOURNAL (2011)
miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma
Shujun Li et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Margot Zoeller
NATURE REVIEWS CANCER (2011)
CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance
Amit S. Adhikari et al.
CANCER RESEARCH (2010)
Osteosarcoma
Richard Gorlick et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Immunoexpression of Ezrin and CD44 in Patients With Osteosarcoma
Erica Boldrini et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
High grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005
Antonio Briccoli et al.
SURGICAL ONCOLOGY-OXFORD (2010)
CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
Yaojiong Wu et al.
STEM CELLS AND DEVELOPMENT (2009)
Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines
Renata Veselska et al.
BMC CANCER (2008)
Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling
R. Tsuchida et al.
ONCOGENE (2008)
Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours
Virginia Tirino et al.
PLOS ONE (2008)
Biology and therapeutic advances for pediatric osteosarcoma
N Marina et al.
ONCOLOGIST (2004)
Antibody to CD14 like CXCR4-specific antibody 12G5 could inhibit CXCR4-dependent chemotaxis and HIV Env-mediated cell fusion
HW Yang et al.
IMMUNOLOGY LETTERS (2003)